[Role of cyclooxygenase-2 in the pathogenesis of chronic liver diseases] (Q79369995)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678698%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

review article

1 reference

title

[Role of cyclooxygenase-2 in the pathogenesis of chronic liver diseases] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678698%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

main subject

chronic liver disease

0 references

author name string

Oscar Núñez Martínez

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678698%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Gerardo Clemente Ricote

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678698%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Carmelo García Monzón

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678698%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678698%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678698%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678698%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678698%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

743-748

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678698%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

cites work

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Cyclooxygenase-2--10 years later

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Eicosanoids and the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Identification of a phorbol ester-repressible v-src-inducible gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-Iiodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active Site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Stimulation of prostaglandin synthesis in cultured liver cells by CCl4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Prostaglandin E2 and rat liver regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Prostacyclin mediates splanchnic vascular response to norepinephrine in portal hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Role of thromboxane A2 in early BDL-induced portal hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Vascular mediators in the injured liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Role of Kupffer cells in alcoholic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Kupffer cell-derived prostaglandin E(2) is involved in alcohol-induced fat accumulation in rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Expression of cyclooxygenase 2 and cytosolic phospholipase A(2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Failure of Ketoprofen and Interferon Combination Therapy to Improve Interferon‐Resistant Chronic Hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Interferon-α increases prostaglandin E2 production by cultured liver biopsy in patients with chronic viral hepatitis: can non-steroidal anti-inflammatory drugs improve the therapeutic response to interferon?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Nonsteroidal anti-inflammatory drug metabolism potentiates interferon alfa signaling by increasing STAT1 phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

The effect of indomethacin on hepatitis B virus replication in chronic healthy carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Review article: COX-2, prostanoids and colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Host cyclooxygenase-2 modulates carcinoma growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Effect of nimesulide on proliferation and apoptosis of human hepatoma SMMC-7721 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Rationale and feasibility of chemoprovention of hepatocellular carcinoma by cyclooxygenase-2 inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Significance of cyclooxygenase-2 expression in human primary hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Cyclooxygenase-2 mRNA is up-regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2974082-2

10.1016/S0025-7753(03)74082-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678698%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference